| Bioactivity | Nicanartine, an orally active antioxidant and lipid-lowering compound, is an antiatherogenic drug[1]. |
| In Vivo | Nicanartine 在球囊导管诱导的内皮损伤后抑制平滑肌细胞增殖，并改善血管反应性，这在胆固醇喂养和渡边兔中通过对乙酰胆碱诱导的扩张反应增加得以体现。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
| CAS | 150443-71-3 |
| Formula | C23H33NO2 |
| Molar Mass | 355.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. H P Hammes, et al. Antioxidant treatment of experimental diabetic retinopathy in rats with nicanartine. Diabetologia. 1997 Jun;40(6):629-34. |